Status:
WITHDRAWN
Effect of High-Flow Nasal Cannula on IVC Measurements Using Point of Care Ultrasound
Lead Sponsor:
Nova Scotia Health Authority
Conditions:
Fluid Overload
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The size of the inferior vena cava (IVC) using point of care ultrasound is used in resuscitation of patients who are critically ill and is now being used as a standard part of resuscitation in many cl...
Detailed Description
Shock is a state of decreased perfusion and inadequate oxygen delivery to tissues. This results in end organ damage and is associated with high morbidity and mortality, regardless of etiology. Shock a...
Eligibility Criteria
Inclusion
- Ambulatory
- 18-40 years old
Exclusion
- Severe lung disease (e.g. poorly controlled asthma, COPD with FEV1 \<40%)
- Congestive heart failure (diastolic dysfunction, ejection fraction \< 50%, severe valvular disorders)
- Renal failure
- Complete nasal obstruction or facial deformities
- BMI \> 30
- Pregnancy
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05264454
Start Date
July 1 2022
End Date
June 30 2023
Last Update
August 21 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
QEII Health Sciences Centre
Halifax, Nova Scotia, Canada, B3H 3G1